para el tratamiento de pacientes adultos con cáncer de pulmón de células no pequeñas (CPCNP) avanzado con una mutación BRAFV600E La aprobación europea se basa en los resultados del ensayo de fase II PHAROS, que mostró […]
Tag: Health Care & Hospitals
5 Key Takeaways for Reducing Risk in Pharma Marketing
RALEIGH, N.C., Aug. 30, 2024 /PRNewswire/ — Group 31 CEO Crystal Weber recently appeared on the podcast The Factor, by Kymanox, where she shared insights into how expert guidance can help biotech and pharma companies navigate […]
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China
BEIJING and SHANGHAI and BOSTON, Aug. 30, 2024 /PRNewswire/ — Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that it has granted the China rights (including mainland China, Hong Kong, Macau, […]
Globalization + Innovation + Asset-light Operations for Sustained and Stable Profits
HONG KONG and SHANGHAI, Aug. 30, 2024 /PRNewswire/ — On 29 August 2024, Guo Guangchang, Chairman of Fosun International stated at the Fosun International 2024 interim results presentation that Fosun aims to build a consumer group […]
Ibuprofen Market to Reach $213.6 Million, Globally, by 2033 at 7.9% CAGR: Allied Market Research
PORTLAND, Ore., Aug. 30, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Ibuprofen Market by Type (Tablet, Capsule, Syrup, Injection, and Other), Application (Rheumatoid Arthritis and Osteoarthritis, Cancer, Pain/Fever/Dysmenorrhea, Inflammatory Diseases, Headache, and Others), […]
